TrialThe Journal of clinical investigation1999

Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis.

J B Travers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.